Moreover, simultaneous inhibition of HSF1 and CBS significantly enhances the suppression of prostate cancer cell proliferation and reduces transsulfuration pathway metabolites, underscoring a potent strategy for tackling prostate cancer progression [102]. Here, CBS is linked to prostate carcinoma.